Systemic lupus erythematosus – Basic Information

Go back

Systemic lupus erythematosus is a complex autoimmune disease where the body’s defense system mistakenly turns against its own healthy tissues, creating a cascade of inflammation that can affect virtually any organ from skin to kidneys, heart to brain. While the condition presents unique challenges with its unpredictable course and varied symptoms, advances in understanding and treatment are helping more people with lupus live fuller, healthier lives than ever before.

Who Gets Lupus: Understanding the Numbers

Systemic lupus erythematosus affects roughly 241 out of every 100,000 people in North America, with approximately 23 new cases diagnosed for every 100,000 individuals each year[1]. The disease shows a striking preference for certain groups. Women develop lupus at nearly ten times the rate of men, making it predominantly a condition affecting female patients[1][3]. When considering age, lupus most commonly makes its first appearance in young women between the ages of 15 and 44, though it can strike at any point in life, from childhood to older age[1][3].

The distribution of lupus across different populations is not equal. In the United States, African Americans, Asian Americans, African Caribbeans, and Hispanic Americans develop the disease more frequently than non-Hispanic white people[1][3]. Native Americans, Alaska Natives, First Nations people, and Pacific Islanders also face higher risks[3]. These disparities extend beyond just developing the disease—certain minority groups also experience more severe forms of lupus and face higher mortality rates, influenced by both genetic factors and differences in access to healthcare[8].

Systemic lupus erythematosus represents the most common form of lupus, accounting for 7 in 10 cases among people with any type of lupus[2]. When most people use the word “lupus,” they are referring to this systemic form. The past several decades have witnessed significant improvements in outcomes—ten-year survival rates now exceed 90%, compared to just 53% survival at five years back in 1955[20]. This dramatic shift reflects better diagnostic tools, more effective treatments, and increased understanding of how to manage this complex condition.

What Causes This Condition

Scientists have not pinpointed a single clear cause of systemic lupus erythematosus, but research suggests the disease develops through a combination of multiple influences working together[1][2]. Understanding these factors helps explain why some people develop lupus while others do not, though it does not yet provide a complete picture.

Genetics play a substantial role in determining who might develop lupus. Family studies reveal that identical twins show concordance rates as high as 50%, meaning if one twin has lupus, the other has a one-in-two chance of developing it as well[4]. More than 100 different gene locations with polymorphisms—variations in genetic code—have been linked to lupus that affects multiple people in different families[4]. These genes typically involve how the immune system responds to foreign substances, how the body generates its own antigens (substances recognized by the immune system), and how both innate and adaptive branches of immunity become activated. Some rare genetic mutations carry particularly high risk: deficiencies in early complement components called C1q, C1r, and C1s create more than a 90% risk of developing lupus, while C4 deficiency carries a 50% risk, and C2 deficiency a 20% risk[4].

Hormones appear to influence lupus development, particularly estrogen, which may help explain why the disease so heavily affects women, especially during childbearing years when estrogen levels are higher[3][10]. Environmental factors also contribute—exposure to ultraviolet light from sunlight, certain toxins like trichloroethylene found in well water, and silica dust have all been implicated in triggering the disease[3]. Some medications can induce a lupus-like syndrome, though this drug-induced form usually resolves after stopping the problematic medication[3]. Viral infections may serve as triggers in susceptible individuals, though specific viruses have not been definitively identified[9].

⚠️ Important
Lupus is not contagious—you cannot catch it from someone else, and you cannot pass it to others through any form of contact. While having a family member with lupus slightly increases your personal risk, most people with lupus do not have relatives with the disease, and most people with affected relatives never develop it themselves.

Who Faces Higher Risk

While anyone can theoretically develop systemic lupus erythematosus, certain groups face substantially elevated risk. Being female dramatically increases the likelihood, with women developing the condition nearly ten times more often than men[1]. The risk peaks during the reproductive years, making women between ages 15 and 44 the most commonly affected group[1][3].

Racial and ethnic background significantly influences risk. Black or African American individuals, Hispanic or Latino people, American Indian and Alaska Native populations, Asian Americans, and Pacific Islanders all develop lupus more frequently than white populations[2][3]. These same groups often experience more severe disease courses and complications.

Having a biological parent or close family member with lupus or another autoimmune disease—conditions where the immune system attacks the body’s own tissues—increases personal risk[2][3]. Smoking represents a modifiable risk factor that not only increases the chance of developing lupus but can worsen symptoms and trigger flares once the disease is present[3][9]. Personal stress levels and having other autoimmune conditions may also contribute to lupus development[3].

Recognizing the Symptoms

Systemic lupus erythematosus earns its reputation as a “great imitator” because its symptoms can mimic many other conditions, making diagnosis challenging. Every person experiences a unique combination and severity of symptoms, which typically come and go rather than remaining constant[1][3]. Symptoms usually develop slowly—you might notice one or two signs initially, then experience additional or different symptoms over time[3].

Nearly everyone with lupus experiences joint pain and swelling at some point during their illness[1]. The fingers, hands, wrists, and knees are commonly affected joints. This joint involvement, sometimes progressing to true arthritis—inflammation of the joints—causes pain and stiffness that can interfere with daily activities.

Skin manifestations are extremely common. About half of people with systemic lupus erythematosus develop a distinctive “butterfly rash” that spreads across the cheeks and bridge of the nose[1][3]. This facial rash, along with other skin rashes, typically worsens with sun exposure, reflecting the photosensitivity—increased sensitivity to ultraviolet light—that many people with lupus experience[1][3]. Mouth sores and hair loss also commonly occur[1][3].

Fatigue represents one of the most troublesome symptoms for many people with lupus. This is not ordinary tiredness that improves with rest—it is an extreme exhaustion that persists no matter how much sleep you get[3][9]. Fever without an obvious infectious cause, unexplained weight loss, and a general feeling of being unwell, called malaise, are also common[1][3].

Because lupus is systemic—affecting the entire body—symptoms depend heavily on which organs the immune system damages. Brain and nervous system involvement can cause headaches, weakness, numbness, tingling sensations, seizures, vision problems, confusion, and personality changes[1]. Heart complications may include inflammation of the heart muscle or the pericardium—the protective sac surrounding the heart—as well as problems with heart valves[1]. Chest pain when taking deep breaths often indicates lung involvement, which might include fluid buildup in the pleural space—the area between the lung and chest wall—difficulty breathing, or even coughing up blood[1][3].

Kidney involvement, called lupus nephritis, can affect up to 60% of people with systemic lupus erythematosus, often within the first five years after symptoms begin[2]. Kidney problems may cause swelling in the legs or elsewhere due to fluid retention[1]. The digestive system may be affected, causing abdominal pain, nausea, and vomiting[1]. Blood abnormalities are common, including anemia—low red blood cell counts—and low counts of white blood cells or platelets—cells that help blood clot[1]. Some people develop blood clots in veins or arteries, inflammation of blood vessels, or Raynaud phenomenon—a condition where arteries constrict in response to cold or stress, causing fingers and toes to turn white or blue[1][3].

More than one in five people with lupus experience neuropsychiatric symptoms affecting the brain, including seizures, stroke, significant memory loss, or trouble thinking clearly[2]. Swollen lymph nodes—small bean-shaped structures that help fight infection—may appear in the neck, armpits, or groin[1][3].

Lupus symptoms typically occur in episodes called flares or relapses, when symptoms worsen or new symptoms appear[3][9]. Between flares, you may experience periods of remission when symptoms diminish or disappear entirely[3]. The unpredictability of flares—their timing and severity—makes living with lupus particularly challenging, as you cannot always predict when symptoms will return or how bad they will be.

Prevention Strategies

Because scientists have not identified a single preventable cause of systemic lupus erythematosus, no guaranteed method exists to prevent the disease from developing in the first place. However, once diagnosed, several strategies can help prevent symptom flares and minimize disease progression.

Avoiding excessive sun exposure represents one of the most important preventive measures. Ultraviolet light from the sun can trigger flares and worsen skin symptoms[7][9]. When you must be outside, especially during peak sunlight hours, cover your arms and legs with clothing, wear a wide-brimmed hat, and apply broad-spectrum sunscreen with SPF 50 or higher[22]. Reapply sunscreen after swimming, sweating, or drying off with a towel. Even indoor lighting can pose problems—fluorescent and halogen lights may also trigger symptoms in some people, so limiting exposure when possible helps[21].

Quitting smoking is crucial not only for preventing lupus development but also for managing existing disease. Smoking can trigger flares, increase their severity, worsen lupus symptoms, and raise the risk of cardiovascular disease, which already occurs at higher rates in people with lupus[9][22].

Maintaining a healthy lifestyle supports overall immune function and reduces inflammation. Eating a balanced diet rich in whole grains, dairy products, fruits, vegetables, and lean proteins provides necessary nutrients[22]. Some research suggests an anti-inflammatory diet emphasizing foods like fatty fish, nuts, olive oil, and foods containing turmeric, ginger, and omega-3 fatty acids may help reduce inflammation, while limiting red meat, fried foods, simple carbohydrates such as white bread and pasta, alfalfa sprouts, and echinacea might be beneficial[26]. Staying physically active with regular exercise—even gentle activities like walking or swimming—can lower stress, improve mood, help fight fatigue, and promote cardiovascular health[7][22].

Getting adequate rest is essential, as fatigue is a hallmark symptom. Aim for seven to nine hours of quality sleep each night and take short breaks throughout the day when needed[22][25]. Managing stress through techniques like meditation, yoga, deep breathing exercises, journaling, or spending quiet time in nature can help prevent stress-triggered flares[7][21][22].

Preventing infections is particularly important because infections represent one of the top causes of death in people with lupus, yet many are preventable through vaccination[26]. Staying current with recommended vaccines—including pneumococcal vaccines, shingles, influenza, COVID-19, and human papillomavirus vaccines—helps protect against serious infections[26]. People with lupus face higher rates of human papillomavirus-related cancers, making HPV vaccination especially important. Those with chronic kidney disease from lupus should receive pneumococcal conjugate vaccine (PCV20 or PCV15), and when PCV15 is used, it should be followed by pneumococcal polysaccharide vaccine (PPSV23)[12]. Maintaining excellent oral health through regular dental care may also help, as poor dental and gum health can worsen lupus inflammation[26].

⚠️ Important
Learning to recognize your personal flare triggers is one of the most powerful prevention tools. Keep a diary noting what you were doing, eating, or experiencing when flares occurred. Common triggers include overwork, lack of sleep, stress, sun exposure, certain lights, infections, injuries, and stopping lupus medications. Once you identify your patterns, you can take steps to avoid or minimize exposure to these triggers.

How Lupus Changes Body Function

Systemic lupus erythematosus fundamentally alters how the immune system works, leading to widespread inflammation and tissue damage throughout the body. In healthy individuals, the immune system distinguishes between foreign invaders like bacteria and viruses versus the body’s own cells and tissues. In lupus, this crucial distinction breaks down—the immune system loses what scientists call “immunological tolerance” and begins producing autoantibodies, which are antibodies that attack the body’s own healthy cells and tissues[4].

The development of these pathogenic autoantibodies represents a central feature of lupus. Nearly all people with systemic lupus erythematosus test positive for antinuclear antibodies (ANA)—antibodies directed against components found in cell nuclei[1][14]. While a positive ANA test alone does not confirm lupus—many people with positive ANA never develop the disease—it serves as an important screening tool. More specific autoantibodies, such as those against double-stranded DNA, provide stronger evidence of lupus and often correlate with disease activity, particularly kidney involvement.

These autoantibodies cause damage through multiple mechanisms. They can form immune complexes—clumps of antibodies bound to antigens—that deposit in various tissues, particularly in the kidneys, blood vessels, skin, and joints. When these complexes accumulate, they trigger intense inflammatory responses. The immune system sends white blood cells to the affected areas, which release chemicals that cause further inflammation, tissue swelling, pain, and progressive damage.

In the kidneys, immune complex deposition in the filtering units called glomeruli leads to inflammation known as glomerulonephritis. This inflammation damages the kidney’s ability to filter blood properly, allowing protein to leak into urine and causing fluid retention that manifests as swelling. Without treatment, progressive kidney damage can lead to chronic kidney disease or even kidney failure requiring dialysis or transplantation.

In the joints, inflammation causes swelling, pain, and stiffness without typically causing the permanent joint destruction seen in rheumatoid arthritis. The skin experiences inflammation that manifests as various types of rashes, the most characteristic being the butterfly-shaped malar rash across the cheeks and nose. Blood vessels throughout the body may become inflamed in a process called vasculitis, which can reduce blood flow to affected organs and cause additional damage.

The blood itself undergoes changes in lupus. Red blood cells may be destroyed prematurely through autoantibody attack, leading to hemolytic anemia. White blood cell and platelet counts often drop due to autoantibody-mediated destruction or decreased production in the bone marrow, increasing infection risk and bleeding tendency respectively.

Lupus can affect the heart in multiple ways. Inflammation of the pericardium causes chest pain that typically worsens with breathing. The heart muscle itself may become inflamed—a condition called myocarditis—affecting its pumping ability. Heart valves can develop abnormalities, and people with lupus face dramatically increased risk of atherosclerosis (hardening of arteries) and heart attacks at younger ages than the general population[12].

In the lungs, inflammation of the pleura—the membrane lining the lungs and chest cavity—causes chest pain with breathing and may lead to fluid accumulation in the pleural space. The lung tissue itself can become inflamed, a condition called pneumonitis, causing shortness of breath and reduced oxygen exchange. Some people develop pulmonary hypertension, where blood pressure in the lung arteries becomes abnormally high, straining the heart.

The nervous system involvement in lupus can be particularly troubling. Inflammation in the brain may cause headaches, cognitive difficulties often described as “brain fog,” mood changes, psychosis, or seizures. Strokes can occur due to blood clots or inflamed blood vessels in the brain. The peripheral nerves—those outside the brain and spinal cord—may also become inflamed, causing numbness, tingling, or weakness.

Many people with lupus develop antiphospholipid antibodies, which increase the tendency for blood to clot inappropriately in veins and arteries. These clots can cause deep vein thrombosis in the legs, pulmonary embolism in the lungs, stroke in the brain, or pregnancy complications including recurrent miscarriages.

Ongoing Clinical Trials on Systemic lupus erythematosus

  • Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Denmark Finland France Germany +9
  • A Study of Idecabtagene Vicleucel CAR-T Cell Therapy for Patients with Autoimmune Diseases That Did Not Respond to B Cell Removal Treatment

    Recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Greece +7
  • Study of Mosunetuzumab Treatment in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on the Safety of CNTY-101 and Aldesleukin for Patients with Active Autoimmune Diseases: Lupus, Scleroderma, and Myositis

    Recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Study on the Effects of Rituximab and Obinutuzumab in Patients with Systemic Lupus Erythematosus (SLE)

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Effects of Belimumab for Patients with Systemic Lupus Erythematosus (SLE)

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Long-term Safety Study of AUTO4 and Rituximab in Patients with Potential Malignancy Treated with Autologous CAR T Cell Therapy

    Recruiting

    1 1 1
    Spain
  • Study on the Safety of MB-CART19.1 for Patients with Active Systemic Lupus Erythematosus, Systemic Sclerosis, or Dermatomyositis/Polymyositis

    Recruiting

    1 1
    Germany
  • Study on the Effects of Belimumab and Rituximab for Patients with Severe Systemic Lupus Erythematosus

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

References

https://medlineplus.gov/ency/article/000435.htm

https://www.lupus.org/resources/what-is-systemic-lupus-erythematosus-sle

https://my.clevelandclinic.org/health/diseases/4875-lupus

https://www.ncbi.nlm.nih.gov/books/NBK535405/

https://www.mayoclinic.org/diseases-conditions/lupus/symptoms-causes/syc-20365789

https://emedicine.medscape.com/article/332244-overview

https://www.cdc.gov/lupus/about/index.html

https://www.nm.org/conditions-and-care-areas/rheumatology/systemic-lupus-erythematosus-sle

https://www.nhs.uk/conditions/lupus/

https://my.clevelandclinic.org/health/diseases/4875-lupus

https://www.mayoclinic.org/diseases-conditions/lupus/diagnosis-treatment/drc-20365790

https://www.aafp.org/pubs/afp/issues/2023/0400/systemic-lupus-erythematosus.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10261264/

https://medlineplus.gov/ency/article/000435.htm

https://emedicine.medscape.com/article/332244-treatment

https://www.lupus.org/news/american-college-of-rheumatology-new-systemic-lupus-erythematosus-guideline

https://www.nature.com/articles/s41573-025-01242-0

https://www.lupus.org/resources/dos-and-donts-for-living-well-with-lupus

https://my.clevelandclinic.org/health/diseases/4875-lupus

https://arthritissj.com/helping-patients-with-sle-thrive-tips-for-living-better-with-lupus/

https://womenshealth.gov/lupus/living-lupus

https://www.parkview.com/blog/how-to-care-for-yourself-when-you-have-lupus

https://www.cdc.gov/lupus/about/index.html

https://www.bassmedicalgroup.com/blog-post/coping-strategies-for-living-with-lupus

https://www.webmd.com/lupus/lupus-tips-everyday-living

https://rheumatology.org/patient-blog/lupus-self-management-take-back-control

FAQ

Can lupus be cured?

There is currently no cure for systemic lupus erythematosus. However, the disease can be effectively managed with proper treatment, and many people achieve remission—periods when they have minimal or no symptoms. The goal of treatment is to control symptoms, prevent flares, minimize organ damage, and maintain quality of life.

Is lupus contagious?

No, lupus is not contagious. You cannot catch it from someone else through any form of contact, nor can you pass it to others. Lupus is an autoimmune disease that develops due to a combination of genetic, hormonal, and environmental factors—not from infection.

Why does lupus affect women more than men?

Women develop lupus nearly ten times more often than men, particularly during childbearing years between ages 15 and 44. Scientists believe hormones, especially estrogen, play a significant role in triggering and affecting the disease, though the exact mechanisms are not fully understood. This hormonal influence may explain why lupus preferentially affects women during their reproductive years.

What is a lupus flare?

A lupus flare is a period when symptoms worsen or new symptoms appear. Flares can vary in severity and duration, and may come with warning signs like increased fatigue, new rashes, fever, or worsening pain. Between flares, people often experience remission when symptoms improve or disappear. Common triggers for flares include sun exposure, stress, lack of sleep, infections, and stopping medications.

Can I have children if I have lupus?

Many women with lupus successfully give birth to healthy children. However, lupus increases risks for pregnancy complications including spontaneous abortions, stillbirths, preeclampsia, and fetal growth restriction. Preconception counseling, careful timing of pregnancy during periods of disease remission, continuing hydroxychloroquine during pregnancy, and close monitoring by a multidisciplinary team are essential for the best outcomes.

🎯 Key takeaways

  • Women develop lupus nearly ten times more often than men, with the highest risk occurring between ages 15 and 44 during reproductive years.
  • African Americans, Hispanic Americans, Asian Americans, Native Americans, and Pacific Islanders face substantially higher risks and often experience more severe disease than white populations.
  • Identical twins show only 50% concordance—highlighting that even with identical genetics, lupus development involves environmental triggers and chance.
  • The distinctive butterfly rash across the cheeks and nose develops in only about half of people with lupus, meaning many people with the disease never develop this classic sign.
  • Up to 60% of people with systemic lupus erythematosus develop kidney involvement (lupus nephritis), typically within the first five years after symptoms begin.
  • Ten-year survival rates have improved dramatically from 53% at five years in 1955 to over 90% today, reflecting major advances in diagnosis and treatment.
  • Ultraviolet light from the sun and even fluorescent or halogen indoor lighting can trigger lupus flares and worsen skin symptoms, making light protection essential.
  • More than one in five people with lupus experience neuropsychiatric symptoms affecting the brain, including memory problems, confusion, seizures, or stroke.